Results 181 to 190 of about 475,199 (278)
Uncovering the biases: why the claimed mask-excess mortality link fails to hold. [PDF]
Cerqueira-Silva T +5 more
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Americans' ideological differences have decreased by race, increased by education. [PDF]
Jessee S.
europepmc +1 more source
Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli +5 more
wiley +1 more source
Weight Trajectories Among Youths Following Residential Relocation.
Saucy A +20 more
europepmc +1 more source
Association of air pollution and atmospheric conditions on pulmonary embolism incidence and severity. [PDF]
Nopp S +5 more
europepmc +1 more source
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht +53 more
wiley +1 more source
Risk-Adjusted Inpatient Falls as Indicators of Health System Performance During the COVID-19 Pandemic. [PDF]
Satoh M, Nakahori T, Shimada T.
europepmc +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Daily profile of COVID-19 infections in Europe - a biophysical perspective. [PDF]
Marsh D.
europepmc +1 more source

